关于 "Nuclear Receptors" 的结果160+ 个结果
- Prepro-Killer Cell Immunoglobulin-Like Receptor 3DL3 (23-31)
Riteau et al. carried out immunofluorescence analysis using a rabbit antiserum directed against the nonapeptide VGGQDKPFL corresponding to the N-terminal sequence of KIR2DL4. The peptide did not discriminate between p49 and KIR2DL4 receptor.
- Protease-Activated Receptor-1, PAR-1 Agonist TFA
Protease-Activated Receptor-1, PAR-1 Agonist TFA 是一种选择性蛋白酶激活受体1 (PAR-1) 激动肽。Protease-Activated Receptor-1, PAR-1 Agonist TFA 对应于 PAR1 配体，可通过该受体选择性地模拟凝血酶的作用。
- Glucocorticoid receptor agonist-1 phosphate Ala-Ala-BrCAS: 2345733-40-4
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br是ADC的药物连接物偶联物，可作为合成抗cd40抗体偶联物(ADC)的反应试剂。
- Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA
Protease-ActivatedReceptor-3(PAR-3)(1-6),humanTFA是一个蛋白酶活化受体3(PAR-3)的激动剂肽。
- NFAT Inhibitor (cell-permeable) (trifluoroacetate salt)
A cell-permeable form of NFAT inhibitor
- EVT-401
EVT-401 (P2X7 receptor antagonist-1) 是一种嘌呤能 P2X7 受体拮抗剂。EVT-401 具有抗神经炎症的作用。
- OT-R antagonist 1CAS: 364071-17-0
OT-R antagonist 1是一种新型有效的选择性非肽类OT-R拮抗剂, 抑制催产素诱发的细胞内Ca2+活动（IC50=8nM）。
- WaTx (36-68) (scorpion) (trifluoroacetate salt)
Wasabi receptor toxin (WaTx) (36-68) is a cell-penetrating peptide that corresponds to the mature toxin sequence and is an activator of transient receptor potential ankyrin 1 (TRPA1).
- IRAK1 (360-380) (trifluoroacetate salt)
IL-1 receptor-associated kinase 1 (IRAK1) (360-380) is a peptide substrate of IRAK4.
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GA23380 | Prepro-Killer Cell Immunoglobulin-Like Receptor 3DL3 (23-31) | - | - | ||
Riteau et al. carried out immunofluorescence analysis using a rabbit antiserum directed against the nonapeptide VGGQDKPFL corresponding to the N-terminal sequence of KIR2DL4. The peptide did not discriminate between p49 and KIR2DL4 receptor. | |||||
| GC62469 | Protease-Activated Receptor-1, PAR-1 Agonist TFA | - | PAR1 | ||
Protease-Activated Receptor-1, PAR-1 Agonist TFA 是一种选择性蛋白酶激活受体1 (PAR-1) 激动肽。Protease-Activated Receptor-1, PAR-1 Agonist TFA 对应于 PAR1 配体，可通过该受体选择性地模拟凝血酶的作用。 | |||||
| GC71233 | Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br | 2345733-40-4 | Glucocorticoid Receptor | ||
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br是ADC的药物连接物偶联物，可作为合成抗cd40抗体偶联物(ADC)的反应试剂。 | |||||
| GC61456 | Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA | - | Peptides | ||
Protease-ActivatedReceptor-3(PAR-3)(1-6),humanTFA是一个蛋白酶活化受体3(PAR-3)的激动剂肽。 | |||||
| GC52384 | NFAT Inhibitor (cell-permeable) (trifluoroacetate salt) | - | Bone Growth & Remodeling | ||
A cell-permeable form of NFAT inhibitor | |||||
| GC90826 | EP4 Antagonist 14 | - | - | ||
一种EP4拮抗剂 | |||||
| GC17547 | MEN 10376 | 135306-85-3 | Neurokinin Receptor | ||
An NK2 receptor antagonist | |||||
| GC67895 | EVT-401 | - | P2X purinergic receptor | ||
EVT-401 (P2X7 receptor antagonist-1) 是一种嘌呤能 P2X7 受体拮抗剂。EVT-401 具有抗神经炎症的作用。 | |||||
| GC36823 | OT-R antagonist 1 | 364071-17-0 | Oxytocin Receptors | ||
OT-R antagonist 1是一种新型有效的选择性非肽类OT-R拮抗剂, 抑制催产素诱发的细胞内Ca2+活动（IC50=8nM）。 | |||||
| GC11312 | EGFR Inhibitor | 879127-07-8 | EGFR | ||
A selective antagonist of the EGFR | |||||
| GC11275 | C34 | 40592-88-9 | HSC | ||
C34是一种可口服的Toll样受体4(TLR4)选择性拮抗剂，C34通过抑制TLR4/MyD88/NF-κB信号通路，减少促炎细胞因子的产生，从而发挥抗炎作用。 | |||||
| GC11134 | ALW-II-41-27 | 1186206-79-0 | Ephrin Receptor | ||
ALW-II-41-27 是一种 Eph 家族酪氨酸激酶抑制剂，抑制 Eph2 的 IC50 为 11 nM。 | |||||
| GC65450 | CT1812 | 1802632-22-9 | Sigma Receptor | ||
CT1812 (Sigma-2 receptor antagonist 1) 是 sigma-2 (σ-2) 受体拮抗剂。 | |||||
| GC36582 | Men 10376 TFA | - | Peptides | ||
An NK2 receptor antagonist | |||||
| GC91865 | WaTx (36-68) (scorpion) (trifluoroacetate salt) | - | Peptides | ||
Wasabi receptor toxin (WaTx) (36-68) is a cell-penetrating peptide that corresponds to the mature toxin sequence and is an activator of transient receptor potential ankyrin 1 (TRPA1). | |||||
| GC92288 | IRAK1 (360-380) (trifluoroacetate salt) | - | - | ||
IL-1 receptor-associated kinase 1 (IRAK1) (360-380) is a peptide substrate of IRAK4. | |||||